Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Mutz

Jörg Mutz, Eschbach DE

Patent application numberDescriptionPublished
20100181098INSULATING PROFILE FOR A CONDUCTOR LINE - The invention relates to an insulating profile for a conductor line having at least one chamber extending in the longitudinal direction of the profile, said chamber being open in cross section to one side, thus defining an open front side of the insulating profile, and being suitable for mounting a busbar, the opening of the open chamber on the front side of the insulating profile expanding in a lateral direction such that the surface of the front side of the insulating profile is slanted toward the center of the nearest open chamber. The conductor line can be a multi-pole conductor line, the insulating profile comprising a regular arrangement of a group of a plurality of chambers extending in the longitudinal direction of the profile and being open to one side and each being suitable for mounting a busbar.07-22-2010
20100252297MULTI-POLE CONDUCTOR LINE - The invention relates to a multi-pole conductor line comprising a plurality of insulating profiles disposed one after another in the longitudinal direction, each having a regular arrangement of a plurality of chambers extending in the longitudinal direction. At least one group of chambers is present that are closed in cross section, and at least one group of chambers that are open to one side and are suitable for mounting one busbar each. Connecting links made of insulating material are provided for connecting the front sides of the insulating profiles. Said links each have as components at least one plug element that can be plugged into a closed chamber of the insulating profile at the front side of an insulating profile, and at least one stop element limiting the plug depth of a plug element into an insulation profile, and preferably at least one catch element by which a form-fit engagement between the connecting link and an insulating profile can be produced.10-07-2010

Jörg Mutz, Eschbach DE

Patent application numberDescriptionPublished
20100181098INSULATING PROFILE FOR A CONDUCTOR LINE - The invention relates to an insulating profile for a conductor line having at least one chamber extending in the longitudinal direction of the profile, said chamber being open in cross section to one side, thus defining an open front side of the insulating profile, and being suitable for mounting a busbar, the opening of the open chamber on the front side of the insulating profile expanding in a lateral direction such that the surface of the front side of the insulating profile is slanted toward the center of the nearest open chamber. The conductor line can be a multi-pole conductor line, the insulating profile comprising a regular arrangement of a group of a plurality of chambers extending in the longitudinal direction of the profile and being open to one side and each being suitable for mounting a busbar.07-22-2010
20100252297MULTI-POLE CONDUCTOR LINE - The invention relates to a multi-pole conductor line comprising a plurality of insulating profiles disposed one after another in the longitudinal direction, each having a regular arrangement of a plurality of chambers extending in the longitudinal direction. At least one group of chambers is present that are closed in cross section, and at least one group of chambers that are open to one side and are suitable for mounting one busbar each. Connecting links made of insulating material are provided for connecting the front sides of the insulating profiles. Said links each have as components at least one plug element that can be plugged into a closed chamber of the insulating profile at the front side of an insulating profile, and at least one stop element limiting the plug depth of a plug element into an insulation profile, and preferably at least one catch element by which a form-fit engagement between the connecting link and an insulating profile can be produced.10-07-2010

Michael Mutz, Freiburg I.br. DE

Patent application numberDescriptionPublished
20080268040Organic Compounds Comprising a Glycopyrrolium Salt - The invention relates to the F-crystal form, G-crystal form, H-crystal form, I-crystal form and K-crystal form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide, certain processes for their preparation, pharmaceutical compositions containing these crystal forms, their use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, and their use as an intermediate or for the preparation of pharmaceutical preparations for use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, especially humans.10-30-2008
20110171301F, G, H, I and K Crystal Forms of Imatinib Mesylate - The invention relates to the F-crystal form, G-crystal form, H-crystal form, I-crystal form and K-crystal form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide, certain processes for their preparation, pharmaceutical compositions containing these crystal forms, their use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, and their use as an intermediate or for the preparation of pharmaceutical preparations for use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, especially humans.07-14-2011
20120015027F, G, H, I and K Crystal Forms of Imatinib Mesylate - The invention relates to the F-crystal form, G-crystal form, H-crystal form, I-crystal form and K-crystal form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(01-19-2012

Patent applications by Michael Mutz, Freiburg I.br. DE

Michael Mutz, Basel CH

Patent application numberDescriptionPublished
20120115840HEMIFUMARATE SALT OF 1-[4-[1-(4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO)-ETHYL]-2-ETHYL-BE- NZYL]-AZETIDINE-3-CARBOXYLIC ACID - This invention relates to a hemifumarate salt of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I), to pharmaceutical compositions comprising this salt, to processes for forming this salt and to its use in medical treatment. In addition, the present invention also relates to new polymorphic forms of the hemifumarate salt form of Compound I, as well as to pharmaceutical compositions comprising these polymorphic forms, to processes for obtaining them, and their use in medical treatment.05-10-2012

Michael Mutz, Freiburg I. Br. DE

Patent application numberDescriptionPublished
20080254116Delta and Epsilon Crystal Forms of Imatinib Mesylate - The invention relates to the delta and epsilon crystal form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide (the compound of formula I, see below), certain processes for their preparation, pharmaceutical compositions containing these crystal forms, and their use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, and their use as an intermediate or for the preparation of pharmaceutical preparations for use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, especially humans.10-16-2008
20090137552Organic Compound - The invention relates to a new crystalline form II of N-benzoyl-staurosporine; compositions containing the same; processes for the preparation thereof; and the use of crystalline form II of N-benzoyl-staurosporine in diagnostic methods or therapeutic treatment of warm-blooded animals, especially humans. The invention relates to the amorphous forms of N-benzoyl-staurosporine; compositions containing the same; processes for the preparation thereof; and the use of amorphous N-benzoyl-staurosporine in diagnostic methods or therapeutic treatment of warm-blooded animals, especially humans.05-28-2009
20120015955F, G, H, I and K Crystal Forms of Imatinib Mesylate - The invention relates to the F-crystal form, G-crystal form, H-crystal form, I-crystal form and K-crystal form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide, certain processes for their preparation, pharmaceutical compositions containing these crystal forms, their use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, and their use as an intermediate or for the preparation of pharmaceutical preparations for use in diagnostic methods or for the therapeutic treatment of warm-blooded animals, especially humans.01-19-2012

Patent applications by Michael Mutz, Freiburg I. Br. DE

Michael Mutz, Freiberg DE

Patent application numberDescriptionPublished
201002860815-AMINO-3-(2',3'-DI-O-ACETYL-BETA-D-RIBOFURANOSYL)-3H-THIAZOLO[4,5-D] PYRIMIDIN-2-OCE SALTS AND CRYSTALLINE FORMS - The invention relates to a maleate salt of 5-amino-3-(2′-3′-di-O-acetyl-beta-D-ribofuranosyl)-3H-thiazolo[4,5-d]pyrimidin-2-one and crystalline forms thereof, their production and usage, and pharmaceutical preparations containing these crystalline forms.11-11-2010

Michael Mutz, Freilburg DE

Patent application numberDescriptionPublished
20110275685SALT AND POLYMORPHS OF A KINESIN INHIBITOR COMPOUND - The present invention relates to salts, polymorphs and hydrates of the kinesin inhibitor compound N-((S)-3-amino-4-fluorobutyl)-N-((R)-1-(1-benzlyl-4-(2,5-difluorophenyl)-1H-imidazol-2-yl)-2,2-dimethylpropyl)-2-hydroxyacetamide, processes to prepare such salts, polymorphs and hydrates and a liquid formulation comprising at least one of these salts, polymorphs and hydrates.11-10-2011

Stephane Mutz, Cuverville FR

Patent application numberDescriptionPublished
20100017886SYSTEM AND METHOD FOR REMOTELY TRACKING AN ACTIVATION OF PROTECTED SOFTWARE - The invention is related to a system (01-21-2010
20120023337ESTABLISHING A SECURE MEMORY PATH IN A UNITARY MEMORY ARCHITECTURE - A functional unit of a device is associated with a secret. Data stored in a memory location of the device is encrypted using the secret. The memory location of the device is accessible to other functional units; but without knowledge of the secret, the stored encrypted data is useless. The sharing of the secret creates a secure path between memory locations and functional units of the device while maintaining a unitary memory architecture. This abstract is not to be considered limiting, since other embodiments may deviate from the features described in this abstract.01-26-2012